2050 Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Blackrock Neurotechblackrockneurotech.comin𝕏May 2021 · $10M
Blackrock Neurotech develops a neurotechnology platform, including brain-computer interface systems, aimed at improving patient lives and treating neurological conditions.
BiotechDeep TechMedical Devices
Florian Solzbacher(Co-Founder & CSO)inMarcus Gerhardt(Co-Founder & CEO)inThomas Thiele(CFO)in
BoardChristian Angermayer(Co-Chairman)Tim Sievers(Co-Chairman)
PartnerCornel Chiriac· solo GP
Co-investorsCatalio Capital Management, LPForepont Capital PartnersPresight CapitalTether
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.







